"*" indicates required fields
A preventable, treatable form of cardiovascular disease. RHD is the most commonly acquired heart disease in young people under the age of 25.
Rheumatic heart disease (RHD) affects the world’s poorest, most vulnerable populations and imposes heavy costs on the health systems that can least afford it. If left untreated, rheumatic heart disease can lead to heart valve damage, stroke, heart failure, and death. Treatment of advanced disease requires costly surgery that is unavailable in many parts of the world. In endemic countries, prevalence of this preventable disease is a stark measure of health system failure and inequality.
RHD is the most commonly acquired heart disease in young people under the age of 25. It most often begins in childhood as strep throat, and can progress to serious heart damage that kills or debilitates adolescents and young adults, and makes pregnancy hazardous.
Although virtually eliminated in Europe and North America, the disease remains common in Africa, the Middle East, Central and South Asia, the South Pacific, and in impoverished pockets of developed nations.
On World Heart Day 2019 in Maputo, Mozambique, WHF launched an educational initiative to raise awareness of RHD – a colouring book that teaches children, teachers and parents about the link between sore throat and RHD.
Mozambique has some of the highest rates of RHD in the world among schoolchildren.
3 3 million people around the world affected by RHD
Following years of campaigning and advocacy from the RHD community, on 25 May 2018, Member States of the World Health Organization unanimously adopted a Global Resolution on Rheumatic Fever and Rheumatic Heart Disease at the World Health Assembly in Geneva, Switzerland.
This historic decision marks the first time that Rheumatic Fever (RF) and Rheumatic Heart Disease (RHD) have been recognised as global health priorities on the world stage. The Resolution was co-sponsored by countries from all six WHO regions, demonstrating the urgent need for a global response.
Following the unanimous adoption of the WHO Resolution on Rheumatic Fever and Rheumatic Heart Disease in May 2018, WHF established a WHF Rheumatic Heart Disease Taskforce (RHDTF) – a global community of health leaders and advocates who are working to consign rheumatic heart disease to the history books by taking targeted actions to support the implementation of the Resolution.
The taskforce has been split into three expert groups based on expertise:
Access to Surgery: The Access to Surgery group of the RHDTF is led by Professor Peter Zilla, a cardiothoracic surgeon based in Cape Town and longtime champion of RHD. Peter heads up the first ever global coalition of cardiothoracic societies dedicated to RHD, the Cardiothoracic Surgery Intersociety Alliance (CSIA) who, alongside the WHF RHD Taskforce shares the joint mission to develop and implement an effective strategy to address the scourge of RHD in low income countries through access to life saving surgery. The CSIA, aims to establish pilot surgical centers with the goal of capacity building for RHD surgery in low income countries.
Policy and Advocacy: The Policy and Advocacy group of the taskforce is concentrating its efforts on narrowing the treatment gap for RHD, in large part due to access and administration issues surrounding Benzathine penicillin G, currently the most efficacious medication for secondary prevention of Rheumatic fever and Rheumatic Heart Disease.
Prevention and Control: The Prevention and Control group will focus on supporting pilot projects which aim to tackle RHD at a more local level.
RHD Action is a global initiative that unites and empowers the rheumatic heart disease community. Led by a coalition of core organizations, RHD Action shares technical advice, advocacy support, and policy insights with partners and allies across the world. Together, we work to create positive change and better health outcomes for people living with RHD and their communities.
The RHD Action website contains a Resource Hub, which is the world’s largest repository of tools and resources for RHD. Materials are available in several languages, and include resources for health professionals, programme coordinators, advocates and people living with RHD. It also includes all resources previously available on the ‘RHD Net’ section of the World Heart Federation website. You can access the Resource Hub for free here.
RHD Action sends out a bi-monthly newsletter RHD Beat, which provides the latest global updates on RHD prevention and control. You can sign up here to subscribe to RHD Beat.
If you have a resource that you would like to submit to the Resource Hub or a piece of news that you would like to submit to RHD Beat, please contact RHD Action at [email protected].
The World Heart Federation (WHF) is excited to announce that the World Health Organization (WHO) has officially released its new Guideline on the Prevention and Diagnosis of Rheumatic Fever and Rheumatic Heart Disease. This key resource represents a major milestone in global efforts to combat rheumatic heart disease – a completely preventable condition that continues […]
Rheumatic Heart Disease
This is a statement delivered by the World Heart Federation at the WHO Executive Board Meeting (EB145) on Agenda Item 19: Social Determinants of Health. Honourable Chair, Distinguished Delegates, The World Heart Federation and its Members welcome the report from the Director-General. However, we note with concern that progress in implementing the recommendations of the […]
Rheumatic Heart Disease
Today, at the first World Congress on Rheumatic Heart Disease in Abu Dhabi, the World Heart Federation is launching the 2023 WHF Guidelines for the Echocardiographic Diagnosis of Rheumatic Heart Disease (RHD), a comprehensive document summarizing the latest available scientific evidence on the management of RHD that can be applied in both clinical and research […]
Rheumatic Heart Disease
This is a statement made at the Pan American Health Organization during the 78th General Assembly of the United Nations in New York. Honorable Chair, Distinguished Delegates, On behalf of the American Heart Association, the InterAmerican Heart Foundation, the Interamerican Society of Cardiology, the Coalition for Americas’ Health and the World Heart Federation, we applaud the Pan […]
Rheumatic Heart Disease